| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/01/2009 | US7625554 Treatment of alzheimer's disease |
| 12/01/2009 | US7625550 Observing tumor progression, angiogenesis and/or metastasis in animal models in real time; employs a skin flap over the area to be observed that can be opened and closed reversibly; simultaneous observation of more than one tumor |
| 12/01/2009 | CA2430607C Self-replicating rna molecule from hepatitis c virus |
| 12/01/2009 | CA2383939C Novel nucleic acid probes, method for determining nucleic acids by using the probes, and method for analyzing data obtained by the method |
| 12/01/2009 | CA2304362C Reagent and method for attaching target molecules to a surface |
| 12/01/2009 | CA2303229C Pentopyranosylnucleoside, its preparation and use |
| 12/01/2009 | CA2157062C Chemiluminescent reagent and assay using a substituted acetanilide for light generation |
| 11/26/2009 | WO2009143504A2 Methods of microrna detection and differentiation |
| 11/26/2009 | WO2009143500A2 Methods for removing nucleic acid contamination from reagents |
| 11/26/2009 | WO2009143478A2 Efficient wellbeing assessment and improved treatment protocol |
| 11/26/2009 | WO2009143476A2 Novel inhibitors of retroviral reverse transcriptase |
| 11/26/2009 | WO2009143444A1 Mobile mangnetic traps and platforms for micro/nano particle manipulation |
| 11/26/2009 | WO2009143379A2 Use of extracellular rna to measure disease |
| 11/26/2009 | WO2009143278A2 Methods of diagnosing and characterizing cannabinoid signaling in crohn's disease |
| 11/26/2009 | WO2009143239A1 Compositions and methods for the treatment and diagnosis of cancer |
| 11/26/2009 | WO2009143212A1 Computer system and computer-facilitated method for nucleic acid sequence alignment and analysis |
| 11/26/2009 | WO2009143181A2 Micro-rna profile in human saliva and its use for detection of oral cancer |
| 11/26/2009 | WO2009143157A2 Self-assembly of nanoparticles through nucleic acid engineering |
| 11/26/2009 | WO2009143089A1 Method, kit and system for collecting and processing samples for dna and rna detection |
| 11/26/2009 | WO2009143081A2 Methods, devices kits and compositions for detecting roundworm |
| 11/26/2009 | WO2009143080A2 Methods, devices, kits and compositions for detecting roundworm |
| 11/26/2009 | WO2009143079A2 Methods, devices, kits and compositions for detecting roundworm |
| 11/26/2009 | WO2009143067A2 Methods, devices, kits and compositions for detecting whipworm |
| 11/26/2009 | WO2009143035A2 Methods and compositions for diagnosing and treating cervical intraepithelial neoplasia and cervical cancer |
| 11/26/2009 | WO2009142744A2 Predicting hemostatic risk; dependence on plasma composition |
| 11/26/2009 | WO2009142735A2 LUCIFERASE BIOSENSORS FOR cAMP |
| 11/26/2009 | WO2009142638A1 Protein assay |
| 11/26/2009 | WO2009142483A2 Genetic markers predicting age at menopause |
| 11/26/2009 | WO2009142474A1 Genetic markers predicting age at menopause |
| 11/26/2009 | WO2009142313A1 Method for searching for gene encoding protein targeted by compound |
| 11/26/2009 | WO2009142303A1 Method for evaluation of function of phagocyte |
| 11/26/2009 | WO2009142271A1 Cancer stem cell having high level of sld5 expression therein |
| 11/26/2009 | WO2009142270A1 Nucleic acid molecule having the capacity to bond with a 2,4,6-trinitrophenyl structure, method for detecting compounds including a 2,4,6-trinitrophenyl structure using said nucleic acid molecule, and use of said nucleic acid molecule |
| 11/26/2009 | WO2009142268A1 Method for evaluation of the state of skin barrier function by natural moisturizing factor of employing the activity of bleomycin hydrolase as measure |
| 11/26/2009 | WO2009142257A1 Composition and method for determination of esophageal cancer |
| 11/26/2009 | WO2009142214A1 Rna in situ hybridization |
| 11/26/2009 | WO2009141926A1 Method for acquisition of compound capable of acting on glucose metabolism/lipid metabolism |
| 11/26/2009 | WO2009141731A2 The large form of human 2', 5'-oligoadenylate synthetase oas3 for preventing or treating infection with positive-sense single-stranded rna viruses |
| 11/26/2009 | WO2009141730A1 Process for detecting botulinum neurotoxin producing organisms |
| 11/26/2009 | WO2009141609A1 Assay for monitoring activity of jmjd6 |
| 11/26/2009 | WO2009141440A1 Netrin-1 overexpression as a biological marker and a survival factor for aggressive neuroblastoma |
| 11/26/2009 | WO2009141430A1 Improved nucleic acid amplification with single strand dna binding protein |
| 11/26/2009 | WO2009141390A1 Method and device for particle analysis using thermophoresis |
| 11/26/2009 | WO2009141301A1 Method for determining the dna repair capacity of a cell |
| 11/26/2009 | WO2009141180A1 Triple function electrodes |
| 11/26/2009 | WO2009141121A1 Method for rapid generation of phosphorylation profiles, the detection of in vivo phosphorylation sites of kinases and phosphatases and their use as diagnostic markers in cells, tissues and body fluids |
| 11/26/2009 | WO2009141066A1 Use of gpr151 modulators for the treatment of pain |
| 11/26/2009 | WO2009140973A1 A combined method for predicting the response to an anti-cancer therapy |
| 11/26/2009 | WO2009140876A1 Integration methods of enriching and detecting rare cells from biological body fluids samples |
| 11/26/2009 | WO2009140802A1 Test probes, common oligonucleotide chips, nucleic acid detection method, and their uses |
| 11/26/2009 | WO2009140796A1 A particle concentration measuring device and method |
| 11/26/2009 | WO2009140741A1 Agents and methods for diagnosing the presence or risk of prostate cancer |
| 11/26/2009 | WO2009140724A1 Herg mutants and uses thereof |
| 11/26/2009 | WO2009118204A3 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung |
| 11/26/2009 | WO2009115594A3 Genetic detection of hiv-1 strains that use the cxcr4 co-receptor |
| 11/26/2009 | WO2009114709A3 Detection of polymeric analytes |
| 11/26/2009 | WO2009111316A3 Barriers for facilitating biological reactions |
| 11/26/2009 | WO2009107966A3 Method of measuring nadph-cytochrome p450 reductase activity in a sample using 5-cyano-2,3-ditolyl tetrazolium chloride as substrate, method of screening a material modulating nadph-cytochrome p450 reductase activity using the method, and kit for measuring nadph-cytochrome p450 reductase activity |
| 11/26/2009 | WO2009105757A3 Methods and compositions for diagnosis of age-related macular degeneration |
| 11/26/2009 | WO2009105533A3 Methods for predicting esophageal adenocarcinoma (eac) |
| 11/26/2009 | WO2009105520A3 Methods, devices, and compositions for the highly-sensitive detection and identification of diverse molecular entities |
| 11/26/2009 | WO2009104937A3 Optical gene code identification system using nanohybrid technology |
| 11/26/2009 | WO2009102632A3 Method for isolating cell free apoptotic or fetal nucleic acids |
| 11/26/2009 | WO2009102470A3 Compositions and methods for use in analytical reactions |
| 11/26/2009 | WO2009102446A3 Fish assay for eml4 and alk fusion in lung cancer |
| 11/26/2009 | WO2009101619A3 Methods for predicting a patient's response to lithium treatment |
| 11/26/2009 | WO2009095596A3 Method, process, and kit for diagnosis or prognosis of colorectal cancer |
| 11/26/2009 | WO2009085277A3 Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| 11/26/2009 | WO2009046972A3 Microarray for expression analysis of cellular glycosylation mechanism |
| 11/26/2009 | WO2009037572A3 Biomarker combinations for colorectal cancer |
| 11/26/2009 | WO2008098256A8 Methods for identifying patients with an increased likelihood of responding to dpp-iv inhibitors |
| 11/26/2009 | WO2008048193A3 Breast tumour grading |
| 11/26/2009 | WO2007140958A9 Method for identifying whether a patient will be responder or not to immunotherapy |
| 11/26/2009 | US20090293157 Production of progenitor cereal cells |
| 11/26/2009 | US20090293152 Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
| 11/26/2009 | US20090293149 transformed host cell or plant comprising nucleic acid fragments encoding plant fatty acid modifying enzymes associated with modification of the delta-9 position of fatty acids; producing fatty acid modifying enzymes associated with the modification |
| 11/26/2009 | US20090293143 Corn regulatory sequences for use as tools in enhancing/improving heterologus genic expression in cells; generating stress, herbicide and disease resistant plants |
| 11/26/2009 | US20090293137 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 11/26/2009 | US20090292482 Methods and Systems for Generating Cell Lineage Tree of Multiple Cell Samples |
| 11/26/2009 | US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity |
| 11/26/2009 | US20090292009 Modulation of stat 6 expression |
| 11/26/2009 | US20090292004 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 11/26/2009 | US20090292002 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 11/26/2009 | US20090291985 Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events |
| 11/26/2009 | US20090291920 Detection of steroid receptors on circulating carcinoma cells and treatment |
| 11/26/2009 | US20090291907 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs |
| 11/26/2009 | US20090291906 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs |
| 11/26/2009 | US20090291905 Fungal phytotoxin fusicoccin for the treatment and diagnosis of coagulation-correlated pathologies |
| 11/26/2009 | US20090291889 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1) |
| 11/26/2009 | US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 11/26/2009 | US20090291856 Diagnostic test for cardiomyopathy |
| 11/26/2009 | US20090291855 Method for confirming the exposure on chrysene |
| 11/26/2009 | US20090291853 Method of predicting risk of lung cancer recurrence, and a composition, kit and microarray for the same |
| 11/26/2009 | US20090291504 Cre complementation using leucine zipper |
| 11/26/2009 | US20090291503 Recombinant Adeno-Associated Virus Production |
| 11/26/2009 | US20090291497 efficient sequence specific gene silencing; gene expression inhibition; increases siRNA efficacy |
| 11/26/2009 | US20090291495 Neural Cell Populations from Primate Pluripotent Stem Cells |
| 11/26/2009 | US20090291470 Chondroitin synthase, method for producing the same and method for producing saccharide chain-extended chondroitin |
| 11/26/2009 | US20090291468 Method and Device for Monitoring Medication Usage |
| 11/26/2009 | US20090291467 Near Infrared Fluorophore for the Selective Labelling of Membranes in Cells |